BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 38
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (6843)
All Articles published online
The chart showing PDF series, HTML series.
Item 
Count 
PDF486
HTML6357
 Sum=6843
Oct 14, 2010 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol 2010; 16(38): 4773-4783 [PMID: 20939105 DOI: 10.3748/wjg.v16.i38.4773]
URL: https://www.wjgnet.com/1007-9327/full/v16/i38/4773.htm
Number Citing Articles
1
Parveen Bazard, Jennifer Pineros, Robert D. Frisina, Mark A. Bauer, Alejandro A. Acosta, Lauren R. Paganella, Dominika Borakiewicz, Mark Thivierge, Freyda L. Mannering, Xiaoxia Zhu, Bo Ding. Cochlear Inflammaging in Relation to Ion Channels and Mitochondrial Functions. Cells 2021; 10(10): 2761 doi: 10.3390/cells10102761
2
Yaxi Chen, Zac Varghese, Xiong Z. Ruan. The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis. Genes & Diseases 2014; 1(1): 106 doi: 10.1016/j.gendis.2014.07.007
3
Chang‐Jiang Yu, Qiu‐Shi Wang, Ming‐Ming Wu, Bin‐Lin Song, Chen Liang, Jie Lou, Liang‐Liang Tang, Xiao‐Di Yu, Na Niu, Xu Yang, Bao‐Long Zhang, Yao Qu, Yang Liu, Zhi‐Chao Dong, Zhi‐Ren Zhang. TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice. Hepatology 2018; 68(5): 1769 doi: 10.1002/hep.30066
4
Midori Honma, Shojiro Sawada, Yoshiyuki Ueno, Keigo Murakami, Tetsuya Yamada, Junhong Gao, Shinjiro Kodama, Tomohito Izumi, Kei Takahashi, Sohei Tsukita, Kenji Uno, Junta Imai, Eiji Kakazu, Yasuteru Kondo, Kei Mizuno, Naoki Kawagishi, Tooru Shimosegawa, Hideki Katagiri. Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. International Journal of Obesity 2018; 42(9): 1544 doi: 10.1038/s41366-018-0062-9
5
Shozo Miyauchi, Teruki Miyake, Masumi Miyazaki, Toru Eguchi, Tetsuji Niiya, Shin Yamamoto, Hidenori Senba, Shinya Furukawa, Bunzo Matsuura, Yoichi Hiasa. Free testosterone concentration is inversely associated with markers of liver fibrosis in men with type 2 diabetes mellitus. Endocrine Journal 2017; 64(12): 1137 doi: 10.1507/endocrj.EJ17-0225
6
Maria Arconzo, Elena Piccinin, Antonio Moschetta. Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators. Digestive and Liver Disease 2021; 53(1): 26 doi: 10.1016/j.dld.2020.05.034
7
Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour. Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease. Chinese Journal of Integrative Medicine 2022; 28(6): 531 doi: 10.1007/s11655-022-3307-3
8
Sharmin Akter. Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology. Middle East Journal of Digestive Diseases 2022; 14(2): 167 doi: 10.34172/mejdd.2022.270
9
Tianran Shen, Xu Chen, Yanping Li, Xilan Tang, Xinwei Jiang, Chao Yu, Yuanzhu Zheng, Honghui Guo, Wenhua Ling. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(6): 1510 doi: 10.1016/j.bbadis.2017.01.027
10
Preena John, Nirav Bhatia, Pravin Kale, Gaurav Doshi. Benefit of Betaine in Isoniazid-Rifampicin-Induced Hepatotoxicity in Rats. Iranian Journal of Toxicology 2023; 17(4): 61 doi: 10.61186/IJT.17.4.61
11
Otto Kučera, Halka Lotková, Pavla Staňková, Miroslav Podhola, Tomáš Roušar, Vojtěch Mezera, Zuzana Červinková. Is rat liver affected by non-alcoholic steatosis more susceptible to the acute toxic effect of thioacetamide?. International Journal of Experimental Pathology 2011; 92(4): 281 doi: 10.1111/j.1365-2613.2011.00765.x
12
Farah Gulzar, Shadab Ahmad, Sushmita Singh, Pawan Kumar, Aditya Sharma, Akhilesh K. Tamrakar. NOD1 activation in 3T3-L1 adipocytes confers lipid accumulation in HepG2 cells. Life Sciences 2023; 316: 121400 doi: 10.1016/j.lfs.2023.121400
13
Jihye Hong, Sera Kim, Hyun-Sook Kim. Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein KinaseαPathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease. Journal of Medicinal Food 2016; 19(6): 549 doi: 10.1089/jmf.2015.3604
14
Ayman M. Mahmoud. Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation. Canadian Journal of Physiology and Pharmacology 2014; 92(9): 717 doi: 10.1139/cjpp-2014-0204
15
Erli Pei, Yang Liu, Weiqing Jiang, Songruo Lin, Lei Huang, Moubin Lin, Li Cai. Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0875-5
16
Xi‐Mei Zhang, Lin Guo, Xiang Huang, Qiu‐Ming Li, Mei‐Hua Chi. 4‐Hydroxynonenal Regulates TNF‐α Gene Transcription Indirectly via ETS1 and microRNA‐29b in Human Adipocytes Induced From Adipose Tissue‐Derived Stromal Cells. The Anatomical Record 2016; 299(8): 1145 doi: 10.1002/ar.23371
17
Luigi Barrea, Paolo Emidio Macchia, Giovanni Tarantino, Carolina Di Somma, Elena Pane, Nicola Balato, Maddalena Napolitano, Annamaria Colao, Silvia Savastano. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0658-y
18
Farouk K. El-Baz, Dalia O. Saleh, Gehad A. Abdel Jaleel, Rehab A. Hussein. Attenuation of Age-Related Hepatic Steatosis by Dunaliella salina Microalgae in Senescence Rats through the Regulation of Redox Status, Inflammatory Indices, and Apoptotic Biomarkers. Advances in Pharmacological and Pharmaceutical Sciences 2020; 2020: 1 doi: 10.1155/2020/3797218
19
Laís Rossi Perazza, Noëmie Daniel, Marie-Julie Dubois, Geneviève Pilon, Thibault Vincent Varin, Mylène Blais, José Luis Martinez Gonzales, Michaël Bouchard, Claude Asselin, Martin Lessard, Yves Pouliot, Denis Roy, André Marette. Distinct Effects of Milk-Derived and Fermented Dairy Protein on Gut Microbiota and Cardiometabolic Markers in Diet-Induced Obese Mice. The Journal of Nutrition 2020; 150(10): 2673 doi: 10.1093/jn/nxaa217
20
Xia Liu, Runzhou Sun, Zhaozhen Li, Ruixin Xiao, Pengfei Lv, Xiangrong Sun, Mark A. Olson, Yanling Gong. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis. Archives of Biochemistry and Biophysics 2021; 711: 109019 doi: 10.1016/j.abb.2021.109019
21
Giovanni Tarantino, Vincenzo Citro, Mauro Cataldi. Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD?. Viruses 2021; 13(7): 1285 doi: 10.3390/v13071285
22
Julie Lasselin, Eric Magne, Cédric Beau, Patrick Ledaguenel, Sandra Dexpert, Agnès Aubert, Sophie Layé, Lucile Capuron. Adipose Inflammation in Obesity: Relationship With Circulating Levels of Inflammatory Markers and Association With Surgery-Induced Weight Loss. The Journal of Clinical Endocrinology & Metabolism 2014; 99(1): E53 doi: 10.1210/jc.2013-2673
23
Gabsik Yang, Hye Eun Lee, Joo Young Lee. A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet. Scientific Reports 2016; 6(1) doi: 10.1038/srep24399
24
Xing-Yu Chen, Cong Wang, Yi-Zhou Huang, Li-Li Zhang. Nonalcoholic fatty liver disease shows significant sex dimorphism. World Journal of Clinical Cases 2022; 10(5): 1457-1472 doi: 10.12998/wjcc.v10.i5.1457
25
Heekyung Choi, Juhyeong Hong, Yuha Seo, Seung‐Hwan Joo, Hanseok Lim, Shayan Fakhraei Lahiji, Yong‐Hee Kim. Self‐Assembled Oligopeptoplex‐Loaded Dissolving Microneedles for Adipocyte‐Targeted Anti‐Obesity Gene Therapy. Advanced Materials 2024; 36(16) doi: 10.1002/adma.202309920
26
Allison J. Wu, Sheryl L. Rifas‐Shiman, Elsie M. Taveras, Emily Oken, Marie‐France Hivert. Associations of DXA‐measured abdominal adiposity with cardio‐metabolic risk and related markers in early adolescence in Project Viva. Pediatric Obesity 2021; 16(2) doi: 10.1111/ijpo.12704
27
Angela Di Porzio, Valentina Barrella, Cristina Gatto, Luisa Cigliano, Maria Stefania Spagnuolo, Raffaella Crescenzo, Ida Romano, Gianluigi Mauriello, Susanna Iossa, Arianna Mazzoli. Protective effect of probiotic Limosilactobacillus reuteri DSM17938 against western diet-induced obesity and associated metabolic alterations. Journal of Functional Foods 2023; 109: 105805 doi: 10.1016/j.jff.2023.105805
28
Beata Kasztelan-Szczerbinska, Agata Surdacka, Maria Slomka, Jacek Rolinski, Krzysztof Celinski, Agata Smolen, Mariusz Szczerbinski. Association of Serum Adiponectin, Leptin, and Resistin Concentrations with the Severity of Liver Dysfunction and the Disease Complications in Alcoholic Liver Disease. Mediators of Inflammation 2013; 2013: 1 doi: 10.1155/2013/148526
29
Hiroki Yoshioka, Shiori Fukaya, Sarah Tominaga, Akito Nagatsu, Nobuhiko Miura, Tohru Maeda. Protective effect of the Kampo formula “Juzen-taiho-to” on isoniazid- and rifampicin-induced hepatotoxicity in mice. Fundamental Toxicological Sciences 2019; 6(1): 25 doi: 10.2131/fts.6.25
30
Taghi Badali, Sara Arefhosseini, Farnaz Rooholahzadegan, Helda Tutunchi, Mehrangiz Ebrahimi-Mameghani. The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial. Health Promotion Perspectives 2023; 13(1): 77 doi: 10.34172/hpp.2023.10
31
D. Gyamfi, H.E. Everitt, V.B. Patel. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2013; : 537 doi: 10.1016/B978-0-12-397154-8.00013-0
32
Sacha Robert, Thomas Gicquel, Aude Bodin, Vincent Lagente, Elisabeth Boichot, Matias A Avila. Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells. PLOS ONE 2016; 11(4): e0153118 doi: 10.1371/journal.pone.0153118
33
Christoph Grander, Felix Grabherr, Herbert Tilg. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovascular Research 2023; 119(9): 1787 doi: 10.1093/cvr/cvad095
34
Jae-Yeo Park, Younghwa Kim, Jee Ae Im, Hyangkyu Lee. Oligonol suppresses lipid accumulation and improves insulin resistance in a palmitate-induced in HepG2 hepatocytes as a cellular steatosis model. BMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0709-1
35
Luciana L.A. Ventura, Nathália C.L. Fortes, Helton C. Santiago, Marcelo V. Caliari, Maria A. Gomes, Dirce R. Oliveira. Obesity-induced diet leads to weight gain, systemic metabolic alterations, adipose tissue inflammation, hepatic steatosis, and oxidative stress in gerbils (Meriones unguiculatus). PeerJ 2017; 5: e2967 doi: 10.7717/peerj.2967
36
Otto Kučera, Tomáš Roušar, Pavla Staňková, Lenka Haňáčková, Halka Lotková, Miroslav Podhola, Zuzana Červinková. Susceptibility of rat non‐alcoholic fatty liver to the acute toxic effect of acetaminophen. Journal of Gastroenterology and Hepatology 2012; 27(2): 323 doi: 10.1111/j.1440-1746.2011.06807.x
37
Anna Alisi, Anna Pastore, Sara Ceccarelli, Nadia Panera, Daniela Gnani, Giovannella Bruscalupi, Mara Massimi, Giulia Tozzi, Fiorella Piemonte, Valerio Nobili. Emodin Prevents Intrahepatic Fat Accumulation, Inflammation and Redox Status Imbalance During Diet-Induced Hepatosteatosis in Rats. International Journal of Molecular Sciences 2012; 13(2): 2276 doi: 10.3390/ijms13022276
38
N. Frank, E. M. Tadros. Insulin dysregulation. Equine Veterinary Journal 2014; 46(1): 103 doi: 10.1111/evj.12169
39
Raika Jamali, Mohsen Razavizade, Abbas Arj, Mohammad Hossein Aarabi. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(21): 5096-5103 doi: 10.3748/wjg.v22.i21.5096
40
Jia Liu, Yuan Xu, Yanjin Hu, Guang Wang. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. Metabolism 2015; 64(3): 380 doi: 10.1016/j.metabol.2014.11.009
41
Ayman M. Mahmoud, Mousa O. Germoush, Ayman S. Soliman. Berberine Attenuates Isoniazid-Induced Hepatotoxicity by Modulating Peroxisome Proliferator-Activated Receptor γ, Oxidative Stress and Inflammation. International Journal of Pharmacology 2014; 10(8): 451 doi: 10.3923/ijp.2014.451.460
42
Linlin Shi, Jie Wang, Yuan Wang, Yi Feng. MDG-1, an Ophiopogon polysaccharide, alleviates hyperlipidemia in mice based on metabolic profile of bile acids. Carbohydrate Polymers 2016; 150: 74 doi: 10.1016/j.carbpol.2016.05.008
43
Mikiko Watanabe, Renata Risi, Elisabetta Camajani, Savina Contini, Agnese Persichetti, Dario Tuccinardi, Ilaria Ernesti, Stefania Mariani, Carla Lubrano, Alfredo Genco, Giovanni Spera, Lucio Gnessi, Sabrina Basciani. Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study. Nutrients 2020; 12(7): 2141 doi: 10.3390/nu12072141
44
Asier Benito-Vicente, Kepa B. Uribe, Noemi Rotllan, Cristina M. Ramírez, Shifa Jebari-Benslaiman, Leigh Goedeke, Alberto Canfrán-Duque, Unai Galicia-García, Diego Saenz De Urturi, Patricia Aspichueta, Yajaira Suárez, Carlos Fernández-Hernando, Cesar Martín. miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression. International Journal of Molecular Sciences 2020; 21(22): 8675 doi: 10.3390/ijms21228675
45
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Maria Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. International Journal of Molecular Sciences 2019; 20(8): 1948 doi: 10.3390/ijms20081948
46
Mitchell Bijnen, Marleen M. J. van Greevenbroek, Carla J. H. van der Kallen, Jean L. Scheijen, Marjo P. H. van de Waarenburg, Coen D. A. Stehouwer, Kristiaan Wouters, Casper G. Schalkwijk. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study. Journal of Diabetes Research 2019; 2019: 1 doi: 10.1155/2019/6289831
47
Farnaz Rooholahzadegan, Sara Arefhosseini, Helda Tutunchi, Taghi Badali, Manuchehr Khoshbaten, Mehrangiz Ebrahimi-Mameghani. The effect of DASH diet on glycemic response, meta-inflammation and serum LPS in obese patients with NAFLD: a double-blind controlled randomized clinical trial. Nutrition & Metabolism 2023; 20(1) doi: 10.1186/s12986-023-00733-4
48
Giovanni Tarantino, Rossella Valentino, Carolina Di Somma, Vittoria D'Esposito, Federica Passaretti, Genoveffa Pizza, Valentina Brancato, Francesco Orio, Pietro Formisano, Annamaria Colao, Silvia Savastano. Bisphenol A in polycystic ovary syndrome and its association with liver–spleen axis. Clinical Endocrinology 2013; 78(3): 447 doi: 10.1111/j.1365-2265.2012.04500.x
49
Sara De Nucci, Caterina Bonfiglio, Rosanna Donvito, Martina Di Chito, Nicole Cerabino, Roberta Rinaldi, Annamaria Sila, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Elsa Lanzilotta, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity. Nutrients 2023; 15(20): 4468 doi: 10.3390/nu15204468
50
Taesic Lee, Tae-Ha Chung. Comparative analysis of the relationship between four hepatic steatosis indices and muscle mass. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-28751-5
51
Amany Abdin, Naglaa Sarhan. Resveratrol protects against experimental induced Reye’s syndrome by prohibition of oxidative stress and restoration of complex I activity. Canadian Journal of Physiology and Pharmacology 2014; 92(9): 780 doi: 10.1139/cjpp-2014-0251
52
Misaq Heydari, María Eugenia Cornide-Petronio, Mónica B. Jiménez-Castro, Carmen Peralta. Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?. International Journal of Molecular Sciences 2020; 21(15): 5242 doi: 10.3390/ijms21155242
53
Alice Chaplin, Ramon Maria Rodriguez, Juan José Segura-Sampedro, Aina Ochogavía-Seguí, Dora Romaguera, Gwendolyn Barceló-Coblijn. Insights behind the Relationship between Colorectal Cancer and Obesity: Is Visceral Adipose Tissue the Missing Link?. International Journal of Molecular Sciences 2022; 23(21): 13128 doi: 10.3390/ijms232113128
54
Şakir Özgür Keşkek, Filiz Ekşi Haydardedeoğlu, Sinan Kırım, Serap Angay, Gülay Ortoğlu, Mehmet Taşdemir, Adil Karaca, Yoel Toledano, Tayyibe Saler. Which increases depressive symptoms in obese patients; hypertension or diabetes?. QScience Connect 2013; (2013): 9 doi: 10.5339/connect.2013.9
55
Yik Lung Chan, Sonia Saad, David Simar, Brian Oliver, Kristine McGrath, David van Reyk, Paul P Bertrand, Cathy Gorrie, Carol Pollock, Hui Chen. Short term exendin‐4 treatment reduces markers of metabolic disorders in female offspring of obese rat dams. International Journal of Developmental Neuroscience 2015; 46(1): 67 doi: 10.1016/j.ijdevneu.2015.05.009
56
Anna Bertolini, Frank A. J. A. Bodewes, Mordechai Slae, Michael Wilschanski. Cystic Fibrosis. Respiratory Medicine 2020; : 299 doi: 10.1007/978-3-030-42382-7_14
57
Sechang Oh, Kiyoji Tanaka, Eiji Warabi, Junichi Shoda. Exercise Reduces Inflammation and Oxidative Stress in Obesity-Related Liver Diseases. Medicine & Science in Sports & Exercise 2013; 45(12): 2214 doi: 10.1249/MSS.0b013e31829afc33
58
Michael Doulberis, Stergios A. Polyzos, Apostolis Papaefthymiou, Panagiotis Katsinelos, Christos Kiosses, Jannis Kountouras. Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents. Expert Opinion on Pharmacotherapy 2020; 21(3): 247 doi: 10.1080/14656566.2019.1702967
59
Constantine E. Kosmas, Hassan Alkhawam, Mohammed El-Hunjul, Gabriel Wagman, Timothy J. Vittorio, Mark R. Kahn, Kathleen M. Grady. Statin-Mediated Low-Density Lipoprotein Lowering in Chronic Congestive Heart Failure. The American Journal of the Medical Sciences 2014; 347(1): 14 doi: 10.1097/MAJ.0b013e318273514c
60
Min-Ji Kim, Min-Su Kim, Han-Byul Lee, Jae-Hyung Roh, Jae-Han Jeon. Relationship between the High Fatty Liver Index and Risk of Fracture. Gut and Liver 2023; 17(1): 119 doi: 10.5009/gnl210571
61
Dagmara Kociszewska, Srdjan Vlajkovic. Age-Related Hearing Loss: The Link between Inflammaging, Immunosenescence, and Gut Dysbiosis. International Journal of Molecular Sciences 2022; 23(13): 7348 doi: 10.3390/ijms23137348
62
Ansoumane Kourouma, Hady Keita, Peng Duan, Chao Quan, Koikoi Kebe Bilivogui, Suqin Qi, Ndjiembi Adjonga Christiane, Aidogie Osamuyimen, Kedi Yang. Effects of 4-nonylphenol on oxidant/antioxidant balance system inducing hepatic steatosis in male rat. Toxicology Reports 2015; 2: 1423 doi: 10.1016/j.toxrep.2015.10.006
63
Non-Alcoholic Fatty Liver Disease is Associated with Higher Metabolic Expenditure in Overweight and Obese Subjects: A Case-Control Study. Nutrients 2019; 11(8): 1830 doi: 10.3390/nu11081830
64
Hyeon-Jeong Kim, Sanghwa Kim, Ah Young Lee, Yoonjeong Jang, Orkhonselenge Davaadamdin, Seong-Ho Hong, Jun Sung Kim, Myung-Haing Cho. The Effects of Gymnema sylvestre in High-Fat Diet-Induced Metabolic Disorders. The American Journal of Chinese Medicine 2017; 45(04): 813 doi: 10.1142/S0192415X17500434
65
Nicola Balato, Maddalena Napolitano, Fabio Ayala, Cataldo Patruno, Matteo Megna, Giovanni Tarantino. Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. World Journal of Gastroenterology 2015; 21(22): 6892-6897 doi: 10.3748/wjg.v21.i22.6892
66
Xiaobing Zhang, Yunfei Song, Yipei Ding, Wei Wang, Ling Liao, Jin Zhong, Pengbo Sun, Fan Lei, Yaou Zhang, Weidong Xie. Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice. Molecules 2018; 23(8): 1894 doi: 10.3390/molecules23081894
67
Xi Li, Yangjun Yang, Yi Sun, Shuzhe Ding. Research Progress on Lipophagy-Mediated Exercise Intervention in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2024; 25(6): 3153 doi: 10.3390/ijms25063153
68
Hongzhi Chen, Juli Bai, Feng Dong, Hezhi Fang, Yun Zhang, Wen Meng, Bilian Liu, Yan Luo, Meilian Liu, Yidong Bai, Muhammad A. Abdul‐Ghani, Rongxia Li, Jiarui Wu, Rong Zeng, Zhiguang Zhou, Lily Q. Dong, Feng Liu. Hepatic DsbA‐L protects mice from diet‐induced hepatosteatosis and insulin resistance. The FASEB Journal 2017; 31(6): 2314 doi: 10.1096/fj.201600985R
69
Annamaria Sila, Sara De Nucci, Caterina Bonfiglio, Vincenza Di Stasi, Nicole Cerabino, Martina Di Chito, Roberta Rinaldi, Paola Cantalice, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Nicoletta Maria Tutino, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity. Nutrients 2024; 16(6): 874 doi: 10.3390/nu16060874
70
Xue Cheng, Dongxiao Gao, Bin Chen, Xueying Mao. Endotoxin-Binding Peptides Derived from Casein Glycomacropeptide Inhibit Lipopolysaccharide-Stimulated Inflammatory Responses via Blockade of NF-κB activation in macrophages. Nutrients 2015; 7(5): 3119 doi: 10.3390/nu7053119
71
Sang R. Lee, Sun Woo Kwon, Pelin Kaya, Young Ho Lee, Jong Geol Lee, Globinna Kim, Geun-Shik Lee, In-Jeoung Baek, Eui-Ju Hong. Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34148-6
72
Lei Liu, Changfa Wang, Zhongyang Hu, Shuwen Deng, Saiqi Yang, Xiaoling Zhu, Yuling Deng, Yaqin Wang. Not only baseline but cumulative exposure of remnant cholesterol predicts the development of nonalcoholic fatty liver disease: a cohort study. Environmental Health and Preventive Medicine 2024; 29(0): 5 doi: 10.1265/ehpm.23-00289
73
Milena N. Stanković, Dušan R. Mladenović, Ivana Đuričić, Slađana S. Šobajić, Jasmina Timić, Bojan Jorgačević, Vuk Aleksić, Danijela B. Vučević, Rada Ješić-Vukićević, Tatjana S. Radosavljević. Time-dependent Changes and Association Between Liver Free Fatty Acids, Serum Lipid Profile and Histological Features in Mice Model of Nonalcoholic Fatty Liver Disease. Archives of Medical Research 2014; 45(2): 116 doi: 10.1016/j.arcmed.2013.12.010
74
Maria-Angeles Aller, Natalia Arias, Isabel Prieto, Luis Santamaria, Maria-Paz de Miguel, Jorge-Luis Arias, Jaime Arias. Portal hypertension-related inflammatory phenotypes: From a vitelline and amniotic point of view. Advances in Bioscience and Biotechnology 2012; 3(07): 881 doi: 10.4236/abb.2012.37110
75
Guiyuan Ji, Yuqi Wang, Yingxun Deng, Xin Li, Zhuoqin Jiang. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy. Lipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0139-6
76
Dong Hun Lee, Il Ho Lee, Jin Tae Hong. Fermented field water-dropwort (Oenanthe javanica) alleviates diet-induced non-alcoholic steatohepatitis. Food and Agricultural Immunology 2022; 33(1): 20 doi: 10.1080/09540105.2021.2022603
77
Yanqi Lan, Zhinan Guo, Junsheng Dai, Kailin Chen, Youlan Chen. Association between remnant cholesterol and metabolic dysfunction-associated steatotic liver disease in the elderly. Digestive and Liver Disease 2024;  doi: 10.1016/j.dld.2024.03.013
78
Wen-Bo Wang, Fei She, Li-Fang Xie, Wen-Hua Yan, Jin-Zhi Ouyang, Bao-An Wang, Hang-Yun Ma, Li Zang, Yi-Ming Mu. Evaluation of Basal Serum Adrenocorticotropic Hormone and Cortisol Levels and Their Relationship with Nonalcoholic Fatty Liver Disease in Male Patients with Idiopathic Hypogonadotropic Hypogonadism. Chinese Medical Journal 2016; 129(10): 1147 doi: 10.4103/0366-6999.181967
79
Arnab Banerjee, Debasmita Das, Sandip Mukherjee, Bithin Kumar Maji. Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis. International Immunopharmacology 2024; 133: 112091 doi: 10.1016/j.intimp.2024.112091
80
Pamela Maffioli, Giuseppe Derosa. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 3 doi: 10.1007/978-94-007-7693-7_24
81
Teresa Auguet, Laia Bertran, Jessica Binetti, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jesús Miguel Lopez-Dupla, José Antonio Porras, David Riesco, Daniel Del Castillo, Cristóbal Richart. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2020; 21(11): 4189 doi: 10.3390/ijms21114189
82
Sunmi Kim, Hyuktae Kwon, Jin-Ho Park, Belong Cho, Donghee Kim, Seung-Won Oh, Cheol Min Lee, Ho-Chun Choi. A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-69
83
Hessah Al‑Muzafar, Kamal Amin. Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl‑CoA desaturase‑1, lipase activity, leptin and resistin. Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6563
84
Adeeb Shehzad, Taewook Ha, Fazli Subhan, Young Sup Lee. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. European Journal of Nutrition 2011; 50(3): 151 doi: 10.1007/s00394-011-0188-1
85
Giovanni Tarantino, Vincenzo Citro, Clara Balsano. Liver-spleen axis in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2021; 15(7): 759 doi: 10.1080/17474124.2021.1914587
86
Yajing Cheng, Wenjin Chen, Jia Xu, Hang Liu, Ting Chen, Jun Hu. Genetic analysis of potential biomarkers and therapeutic targets in age-related hearing loss. Hearing Research 2023; 439: 108894 doi: 10.1016/j.heares.2023.108894
87
Giovanni Tarantino, Vincenzo Citro. Could Adverse Effects of Antibiotics Due to Their Use/Misuse Be Linked to Some Mechanisms Related to Nonalcoholic Fatty Liver Disease?. International Journal of Molecular Sciences 2024; 25(4): 1993 doi: 10.3390/ijms25041993
88
Jordi Camps, Esther Rodríguez-Gallego, Anabel García-Heredia, Iris Triguero, Marta Riera-Borrull, Anna Hernández-Aguilera, Fedra Luciano-Mateo, Salvador Fernández-Arroyo, Jorge Joven. . Advances in Clinical Chemistry 2014; 63: 247 doi: 10.1016/B978-0-12-800094-6.00007-8
89
Giovanni Tarantino, Carmine Finelli. Handbook of Lipids in Human Function. 2016; : 731 doi: 10.1016/B978-1-63067-036-8.00028-7
90
Akinobu Nakamura, Yasuo Terauchi. Lessons from Mouse Models of High-Fat Diet-Induced NAFLD. International Journal of Molecular Sciences 2013; 14(11): 21240 doi: 10.3390/ijms141121240
91
Walaa Hegazy, Adel Abdel-Moneim, Eman S. Abdel-Rehiem, Marwa Salah, Manal Abdul-Hamid. The protective effect of hesperidin on the liver of hypothyroid rats mediated by nuclear factor erythroid 2-related factor 2-dependent activation of heme oxygenase 1. Journal of Molecular Histology 2022; 53(3): 543 doi: 10.1007/s10735-022-10066-w
92
Avni Mody, Donna White, Fasiha Kanwal, Jose M. Garcia. Relevance of low testosterone to nonalcoholic fatty liver disease. Cardiovascular Endocrinology 2015; 4(3): 83 doi: 10.1097/XCE.0000000000000057
93
Emina Čolak, Dragana Pap. The role of oxidative stress in the development of obesity and obesity-related metabolic disorders. Journal of Medical Biochemistry 2021; 40(1): 1 doi: 10.5937/jomb0-24652
94
Anna Hadjihambi. Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease?. Analytical Biochemistry 2022; 636: 114387 doi: 10.1016/j.ab.2021.114387
95
Guanghua Xiong, Yunyun Deng, Xinjun Liao, Jun’e Zhang, Bo Cheng, Zigang Cao, Huiqiang Lu. Graphene oxide nanoparticles induce hepatic dysfunction through the regulation of innate immune signaling in zebrafish (Danio rerio). Nanotoxicology 2020; 14(5): 667 doi: 10.1080/17435390.2020.1735552
96
Silvia Savastano, Carolina Di Somma, Luigi Barrea, Annamaria Colao. The complex relationship between obesity and the somatropic axis: The long and winding road. Growth Hormone & IGF Research 2014; 24(6): 221 doi: 10.1016/j.ghir.2014.09.002
97
I-Pin Chou, Yao-Pang Chiu, Shih-Torng Ding, Bing-Hsien Liu, Yuan Yu Lin, Ching-Yi Chen. Adiponectin receptor 1 overexpression reduces lipid accumulation and hypertrophy in the heart of diet-induced obese mice – possible involvement of oxidative stress and autophagy. Endocrine Research 2014; 39(4): 173 doi: 10.3109/07435800.2013.879165
98
Soumojit Pal, Poulomi Nath, Debabrata Das, Sudip Hajra, Sudipta Maitra. Cross-talk between insulin signalling and LPS responses in mouse macrophages. Molecular and Cellular Endocrinology 2018; 476: 57 doi: 10.1016/j.mce.2018.04.009
99
Pamela Maffioli, Giuseppe Derosa. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7745-3_24-1
100
Mary Sugden, Mark Holness. Recent advances in biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis: the role of lipid analysis/ profiling. Clinical Lipidology 2011; 6(4): 427 doi: 10.2217/clp.11.30
101
Stefanos Tyrovolas, Demosthenes B. Panagiotakos, Ekavi N. Georgousopoulou, Christina Chrysohoou, John Skoumas, William Pan, Dimitrios Tousoulis, Christos Pitsavos. The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study. Therapeutic Advances in Gastroenterology 2019; 12: 175628481985803 doi: 10.1177/1756284819858039
102
Giovanni Tarantino, Carmine Finelli, Franco Scopacasa, Fabrizio Pasanisi, Franco Contaldo, Domenico Capone, Silvia Savastano. Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes. Oxidative Medicine and Cellular Longevity 2014; 2014: 1 doi: 10.1155/2014/920676
103
Sung Woo Choi, Heeseung Oh, Seung Yeon Park, Wonjun Cho, A.M. Abd El-Aty, Nurcan Kilic Baygutalp, Ji Hoon Jeong, Tae Woo Jung. Netrin-1 attenuates hepatic steatosis via UNC5b/PPARγ-mediated suppression of inflammation and ER stress. Life Sciences 2022; 311: 121149 doi: 10.1016/j.lfs.2022.121149
104
Anna Hernández-Aguilera, Anna Rull, Esther Rodríguez-Gallego, Marta Riera-Borrull, Fedra Luciano-Mateo, Jordi Camps, Javier A. Menéndez, Jorge Joven. Mitochondrial Dysfunction: A Basic Mechanism in Inflammation-Related Non-Communicable Diseases and Therapeutic Opportunities. Mediators of Inflammation 2013; 2013: 1 doi: 10.1155/2013/135698
105
Lynn H. Gerber, Ali Weinstein, Lisa Pawloski. Role of Exercise in Optimizing the Functional Status of Patients with Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2014; 18(1): 113 doi: 10.1016/j.cld.2013.09.016
106
Marta Melis, Xiao-Han Tang, Steven E. Trasino, Viral M. Patel, Daniel J. Stummer, Jose Jessurun, Lorraine J. Gudas, Michael Schubert. Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease. PLOS ONE 2019; 14(1): e0211071 doi: 10.1371/journal.pone.0211071
107
Jordi Camps, Anabel García-Heredia. Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics. Advances in Experimental Medicine and Biology 2014; 824: 1 doi: 10.1007/978-3-319-07320-0_1
108
Federico Greco, Claudia Lucia Piccolo, Valerio D’Andrea, Arnaldo Scardapane, Bruno Beomonte Zobel, Carlo Augusto Mallio. Fat Matters: Exploring Cancer Risk through the Lens of Computed Tomography and Visceral Adiposity. Journal of Clinical Medicine 2024; 13(2): 453 doi: 10.3390/jcm13020453
109
Hae Jin Yang, Sang Goon Shim, Bong Oh Ma, Ji Yeong Kwak. Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men. European Journal of Gastroenterology & Hepatology 2016; 28(3): 338 doi: 10.1097/MEG.0000000000000535
110
Liqing Jiang, Qian Wang, Yingsong Jiang, Dadi Peng, Kezhen Zong, Shan Li, Wenyuan Xie, Cheng Zhang, Kaili Li, Zhongjun Wu, Zuotian Huang. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer’s disease through machine learning algorithms. Clinica Chimica Acta 2024; 557: 117892 doi: 10.1016/j.cca.2024.117892
111
Debrup Chakraborty, Jing Wang. Nonalcoholic fatty liver disease and colorectal cancer: Correlation and missing links. Life Sciences 2020; 262: 118507 doi: 10.1016/j.lfs.2020.118507
112
Hong-Ai Zhang, Xiao-Yan Yang, Yan-Feng Xiao. AMPKα1 overexpression alleviates the hepatocyte model of nonalcoholic fatty liver disease via inactivating p38MAPK pathway. Biochemical and Biophysical Research Communications 2016; 474(2): 364 doi: 10.1016/j.bbrc.2016.04.111
113
Sara Shojaei‐Zarghani, Ali Reza Safarpour, Mohammad Reza Fattahi, Abbasali Keshtkar. Sodium in relation with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of observational studies. Food Science & Nutrition 2022; 10(5): 1579 doi: 10.1002/fsn3.2781
114
Marco Bertolotti, Amedeo Lonardo, Chiara Mussi, Enrica Baldelli, Elisa Pellegrini, Stefano Ballestri, Dante Romagnoli, Paola Loria. Nonalcoholic fatty liver disease and aging: Epidemiology to management. World Journal of Gastroenterology 2014; 20(39): 14185-14204 doi: 10.3748/wjg.v20.i39.14185
115
Yong Jian Zhou, Zong Sheng Zhang, Yu Qiang Nie, Jie Cao, Chuang Yu Cao, Yu Yuan Li. Retracted: Association of adiponectin gene variation with progression of nonalcoholic fatty liver disease: A 4‐year follow‐up survey. Journal of Digestive Diseases 2015; 16(10): 601 doi: 10.1111/1751-2980.12288
116
Sherif M. Shoieb, Mahmoud A. El-Ghiaty, Mohammed A. Alqahtani, Ayman O.S. El-Kadi. Cytochrome P450-derived eicosanoids and inflammation in liver diseases. Prostaglandins & Other Lipid Mediators 2020; 147: 106400 doi: 10.1016/j.prostaglandins.2019.106400
117
Iben M. Miller, Astrid Vindsand Naver, Ulla B. Mogensen, Kian Zarchi, Hans C. Ring, Christina Ellervik, Gregor B.E. Jemec. Gallstones are associated with hidradenitis suppurativa. European Journal of Gastroenterology & Hepatology 2015; 27(12): 1392 doi: 10.1097/MEG.0000000000000469
118
Raghdaa Al Zarzour, Mohammed Alshawsh, Muhammad Asif, Majed Al-Mansoub, Zahurin Mohamed, Mariam Ahmad, Amin Abdul Majid, Mohd. Asmawi, Gurjeet Kaur, Dhamraa Al-dualimi, Mun Yam. Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease. Nutrients 2018; 10(8): 1057 doi: 10.3390/nu10081057
119
Jaw Long Sun, Jinwoo Park, Taeseung Lee, Ji Hoon Jeong, Tae Woo Jung. DEL-1 ameliorates high-fat diet-induced insulin resistance in mouse skeletal muscle through SIRT1/SERCA2-mediated ER stress suppression. Biochemical Pharmacology 2020; 171: 113730 doi: 10.1016/j.bcp.2019.113730
120
Mohamed Asrih, François R Jornayvaz. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. Journal of Endocrinology 2013; 218(3): R25 doi: 10.1530/JOE-13-0201
121
Soo Jin Yang, Yunsook Lim. Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation. Metabolism 2014; 63(5): 693 doi: 10.1016/j.metabol.2014.02.003
122
Asieh Mansour, Soudabe Motamed, Azita Hekmatdoost, Sara Karimi, Mohammad Reza Mohajeri-Tehrani, Mohammad Abdollahi, Reihane Jelodar, Sayed Mahmoud Sajjadi-Jazi. Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-30945-w
123
Anna Pastore, Anna Alisi, Gianna di Giovamberardino, Annalisa Crudele, Sara Ceccarelli, Nadia Panera, Carlo Dionisi-Vici, Valerio Nobili. Plasma Levels of Homocysteine and Cysteine Increased in Pediatric NAFLD and Strongly Correlated with Severity of Liver Damage. International Journal of Molecular Sciences 2014; 15(11): 21202 doi: 10.3390/ijms151121202
124
Jayden Abdallah, Samantha Assaf, Arpita Das, Vasant Hirani. Effects of anti-inflammatory dietary patterns on non-alcoholic fatty liver disease: a systematic literature review. European Journal of Nutrition 2023; 62(4): 1563 doi: 10.1007/s00394-023-03085-0
125
Wei Wang, Caiyan Zhao, Junying Zhou, Zhen Zhen, Yadong Wang, Chuan Shen, Carlos M Rodriguez-Ortigosa. Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis. PLoS ONE 2013; 8(10): e76538 doi: 10.1371/journal.pone.0076538
126
Okan Dikker, Hüseyin Dağ, Emine Türkkan, Nevin Çetin Dağ, Nafiye Emel Çakar. The relationship between zinc and hepatic steatosis. Journal of Surgery and Medicine 2019;  doi: 10.28982/josam.608618
127
Carmine Finelli, Giovanni Tarantino. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?. Hepatology International 2013; 7(2): 413 doi: 10.1007/s12072-012-9406-z
128
Maria-Angeles Aller, Natalia Heras, Javier Blanco-Rivero, Jose-Ignacio Arias, Vicente Lahera, Gloria Balfagón, Jaime Arias. Portal hypertensive cardiovascular pathology: The rescue of ancestral survival mechanisms?. Clinics and Research in Hepatology and Gastroenterology 2012; 36(1): 35 doi: 10.1016/j.clinre.2011.07.017
129
Silvia Savastano, Carolina Di Somma, Annamaria Colao, Luigi Barrea, Francesco Orio, Carmine Finelli, Fabrizio Pasanisi, Franco Contaldo, Giovanni Tarantino. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status. Growth Hormone & IGF Research 2015; 25(1): 28 doi: 10.1016/j.ghir.2014.10.006
130
Kyung Eun Kim, Youngae Jung, Soonki Min, Miso Nam, Rok Won Heo, Byeong Tak Jeon, Dae Hyun Song, Chin-ok Yi, Eun Ae Jeong, Hwajin Kim, Jeonghyun Kim, Seon-Yong Jeong, Woori Kwak, Do Hyun Ryu, Tamas L. Horvath, Gu Seob Roh, Geum-Sook Hwang. Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism. Scientific Reports 2016; 6(1) doi: 10.1038/srep30111
131
James W. Little, Donald A. Falace, Craig S. Miller, Nelson L. Rhodus. Little and Falace's Dental Management of the Medically Compromised Patient. 2013; : 144 doi: 10.1016/B978-0-323-08028-6.00010-5
132
Un Jung, Myung-Sook Choi. Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2014; 15(4): 6184 doi: 10.3390/ijms15046184
133
Matteo Nicola Dario Di Minno, Rosario Peluso, Salvatore Iervolino, Roberta Lupoli, Anna Russolillo, Giovanni Tarantino, Raffaele Scarpa. Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study. Arthritis Research & Therapy 2012; 14(5): R211 doi: 10.1186/ar4049
134
Mi Young Lee, Ran Choi, Hong Min Kim, Eun Ju Cho, Bo Hwan Kim, Yeon Sik Choi, Jarinyaporn Naowaboot, Eun Young Lee, Young Chul Yang, Jang Yel Shin, Young Goo Shin, Choon Hee Chung. Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism. Experimental & Molecular Medicine 2012; 44(10): 578 doi: 10.3858/emm.2012.44.10.066
135
Mathilde Foisy Sauvé, Schohraya Spahis, Edgard Delvin, Emile Levy. Glycomacropeptide: A Bioactive Milk Derivative to Alleviate Metabolic Syndrome Outcomes. Antioxidants & Redox Signaling 2021; 34(3): 201 doi: 10.1089/ars.2019.7994
136
L. F. Torres, B. Cogliati, R. Otton. Green Tea Prevents NAFLD by Modulation of miR-34a and miR-194 Expression in a High-Fat Diet Mouse Model. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/4168380
137
Michal Ganz, Terence N Bukong, Timea Csak, Banishree Saha, Jin-Kyu Park, Aditya Ambade, Karen Kodys, Gyongyi Szabo. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat–cholesterol–sugar diet model in mice. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0552-7
138
Christopher Leung, Leni Rivera, John B. Furness, Peter W. Angus. The role of the gut microbiota in NAFLD. Nature Reviews Gastroenterology & Hepatology 2016; 13(7): 412 doi: 10.1038/nrgastro.2016.85
139
Sara Arefhosseini, Neda Roshanravan, Helda Tutunchi, Somayyeh Rostami, Manuchehr Khoshbaten, Mehrangiz Ebrahimi-Mameghani. Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1092544
140
María-Angeles Aller, Natalia Arias, Sherezade Fuentes-Julian, Alejandro Blazquez-Martinez, Salvador Argudo, Maria-Paz de Miguel, Jorge-Luis Arias, Jaime Arias. Coupling inflammation with evo-devo. Medical Hypotheses 2012; 78(6): 721 doi: 10.1016/j.mehy.2012.02.018
141
Jareth Jun Jie Ng, Wai Mun Loo, Kewin Tien Ho Siah. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review. World Journal of Hepatology 2023; 15(7): 925-938 doi: 10.4254/wjh.v15.i7.925
142
H. Nishizawa, G. Iguchi, A. Murawaki, H. Fukuoka, Y. Hayashi, H. Kaji, M. Yamamoto, K. Suda, M. Takahashi, Y. Seo, Y. Yano, R. Kitazawa, S. Kitazawa, M. Koga, Y. Okimura, K. Chihara, Y. Takahashi. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy. European Journal of Endocrinology 2012; 167(1): 67 doi: 10.1530/EJE-12-0252
143
Jharna Puppala, Siva Prasad Siddapuram, Jyothy Akka, Anjana Munshi. Genetics of Nonalcoholic Fatty Liver Disease: An Overview. Journal of Genetics and Genomics 2013; 40(1): 15 doi: 10.1016/j.jgg.2012.12.001
144
Hangkai Huang, Yanjun Guo, Zhening Liu, Yan Zeng, Yishu Chen, Chengfu Xu. Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction–associated Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism 2022; 107(8): e3295 doi: 10.1210/clinem/dgac283
145
Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng. Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study. Intestinal Research 2024;  doi: 10.5217/ir.2023.00078
146
Elena Daveri, Eleonora Cremonini, Angela Mastaloudis, Shelly N. Hester, Steven M. Wood, Andrew L. Waterhouse, Mauri Anderson, Cesar G. Fraga, Patricia I. Oteiza. Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice. Redox Biology 2018; 18: 16 doi: 10.1016/j.redox.2018.05.012
147
Ran Cui, Hui Sheng, Xue-Fei Rui, Xiao-Yun Cheng, Chun-Jun Sheng, Ji-Ying Wang, Shen Qu. Low Bone Mineral Density in Chinese Adults with Nonalcoholic Fatty Liver Disease. International Journal of Endocrinology 2013; 2013: 1 doi: 10.1155/2013/396545
148
Sarahi Lopez‐Esparza, Laura C. Berumen, Karla Padilla, Ricardo Miledi, Guadalupe García‐Alcocer. Expression of hippocampal serotonin receptors 5‐HT2C and 5‐HT5A in a rat model of diet‐induced obesity supplemented with tryptophan. International Journal of Developmental Neuroscience 2015; 42(1): 80 doi: 10.1016/j.ijdevneu.2015.02.010
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345